Kyungchan Min
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Target trial emulation of survival outcomes for clinically localized prostate cancer treatments.
Journal: Discover oncology
Published: March 20, 2026
Association of long-term 5α-reductase inhibitor use with survival in men with renal cell carcinoma: a nationwide population-based cohort study.
Journal: Frontiers in pharmacology
Published: February 14, 2026
Comparison of the efficacy and safety of metallic ureteral stent versus polymer ureteral stent for patients with malignant ureteral obstruction: a meta-analysis of comparative trials.
Journal: World journal of urology
Published: November 17, 2025
Corrigendum to "Microbiome-derived indole-3-lactic acid reduces amyloidopathy through aryl-hydrocarbon receptor activation" [Brain Behav. Immun. 122 (2024) 568-582].
Journal: Brain, behavior, and immunity
Published: April 18, 2025
Impact of tumor size and sex on diagnostic discrepancies in renal mass imaging.
Journal: Scientific reports
Published: April 09, 2025
Oncologic outcomes of salvage radiotherapy and lymphadenectomy for positron emission tomography-positive lymph nodes in biochemical recurrence: A systematic review to inform treatment decisions.
Journal: Prostate international
Published: March 14, 2025
Differential Urinary Microbiome and Its Metabolic Footprint in Bladder Cancer Patients Following BCG Treatment.
Journal: International journal of molecular sciences
Published: August 21, 2024
Trimethylamine-producing microbe Bacillus megaterium KCTC 3007 promotes antitumor immunity in endometrial cancer via type I interferon response pathways.
Journal: Microbiome
Published: July 15, 2024
Microbiome-derived indole-3-lactic acid reduces amyloidopathy through aryl-hydrocarbon receptor activation.
Journal: Brain, behavior, and immunity
Published: January 09, 2024
Fecal microbiota transplantation improves anti-PD-1 inhibitor efficacy in unresectable or metastatic solid cancers refractory to anti-PD-1 inhibitor.
Journal: Cell host & microbe
Published: October 17, 2023
Last Updated: 09/26/2026